AIoT Health

AIoT Health, founded in 2020 and based in Calgary, Canada, focuses on enhancing healthcare through the integration of digital technology and machine learning. The company aims to improve treatment outcomes by analyzing how individuals within a cohort respond to various therapies, thereby paving the way for personalized medicine. By leveraging portable technology and biofeedback, AIoT Health seeks to increase patient engagement and facilitate continuous healthcare improvement without the necessity for new procedures or drugs. Their approach emphasizes the collection of longitudinal data to uncover new metrics and treatment options, ultimately striving to create a more nuanced understanding of individual health responses and advancing healthcare delivery.

Amol Deshpande

Partner

Kar Leung

Partner

Matt Mayer

Partner

4 past transactions

Arcascope

Seed Round in 2022
Arcascope is a technology company that specializes in developing health and fitness applications. Their primary focus is on creating apps that utilize algorithms to track users' circadian rhythms. By analyzing data from phones and wearable devices, Arcascope accurately monitors the body's internal clock. This information is used to generate personalized recommendations aimed at helping individuals manage their fatigue and improve their overall well-being by aligning with their natural sleep-wake cycles.

SeamlessMD

Series A in 2020
SeamlessMD is a developer of a digital patient engagement platform focused on improving health outcomes for patients undergoing surgery. The company addresses the challenges of traditional surgical care, which often relies on paper instructions and human memory, by utilizing design, data, and technology to enhance the patient experience. SeamlessMD's platform supports hospitals in engaging patients through remote monitoring and data collection, which helps optimize recovery processes and reduce readmission rates. By collaborating with healthcare providers, SeamlessMD aims to deliver high-quality surgical care while lowering costs, ultimately ensuring patients have a better and more informed journey through their surgical experiences.

DrugBank

Seed Round in 2020
DrugBank is a developer of a comprehensive drug knowledge platform aimed at enhancing healthcare delivery and accelerating drug research. Their robust database provides extensive information on pharmaceuticals, including mechanisms of action, drug interactions, and allergy information, which empowers healthcare professionals to make informed decisions. The platform includes tools for drug search, interaction checking, and access to drug labels, facilitating precision medicine and clinical software applications. By integrating these resources into various software solutions via their API, DrugBank enables companies to scale their usage and expedite the development of novel drug candidates and predictive machine learning models. Additionally, DrugBank Online offers a free-to-use resource with limited datasets for academic and non-commercial research, contributing to its recognition in over 13,000 academic publications and its widespread use among millions of researchers and health professionals worldwide.

Alio

Convertible Note in 2020
Alio is a company specializing in remote patient monitoring technology aimed at improving care for dialysis patients and reducing avoidable hospitalizations. Founded in 2012 and headquartered in Broomfield, Colorado, Alio develops wearable medical devices that monitor critical health metrics, including skin temperature, oxygen saturation, pulse rate variability, blood pressure, potassium, and hemoglobin. This technology empowers patients to manage their health more effectively while equipping physicians with actionable real-time data to support informed medical decision-making.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.